Breaking News Instant updates and real-time market news.

IGXT

IntelGenx

$0.00 /

+ (+0.00%)

08:23
02/17/21
02/17
08:23
02/17/21
08:23

IntelGenx receives Notice of Allowance for patent application for THC oral film

IntelGenx Corp announced that the United States Patent and Trademark Office has granted a Notice of Allowance for US Patent Application 16/110,737, entitled "Film Dosage Form with Extended Release Mucoadhesive Particles." This film formulation patent covers novel disintegrating oral film formulations designed for the transmucosal absorption of drug, especially tetrahydrocannabinol, and is intended to protect IntelGenx's DisinteQ products.

TODAY'S FREE FLY STORIES

Recommendations
Microsoft price target raised to $300 from $275 at Argus » 07:37
04/13/21
04/13
07:37
04/13/21
07:37
MSFT

Microsoft

$255.89 /

+0.16 (+0.06%)

, NUAN

Nuance

$52.80 /

+7.21 (+15.81%)

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

06:57 Today BMO Capital
BMO Capital positive on Microsoft deal for Nuance
04/12/21 Jefferies
Microsoft deal emphasizes healthcare cloud focus, says Jefferies
04/12/21 Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
04/12/21 B. Riley
Nuance possible takeout positive for peer LivePerson, says B. Riley
NUAN Nuance
$52.80 /

+7.21 (+15.81%)

06:57 Today BMO Capital
BMO Capital positive on Microsoft deal for Nuance
06:22 Today Wedbush
Nuance downgraded to Neutral from Outperform at Wedbush
04/12/21 Jefferies
Microsoft deal emphasizes healthcare cloud focus, says Jefferies
04/12/21 Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

MSFT Microsoft
$255.89 /

+0.16 (+0.06%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

Hot Stocks
BridgeBio announces collaboration agreement with The Lundquist Institute » 07:36
04/13/21
04/13
07:36
04/13/21
07:36
BBIO

BridgeBio

$53.97 /

-0.51 (-0.94%)

BridgeBio Pharma and The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

03/22/21 Goldman Sachs
BridgeBio price target raised to $91 from $83 at Goldman Sachs
03/22/21 Piper Sandler
BridgeBio's encaleret likely to be new standard of care, says Piper Sandler
03/04/21 Mizuho
BridgeBio price target raised to $86 from $56 at Mizuho
03/01/21 Piper Sandler
BridgeBio's first approval small but significant, says Piper Sandler
BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

  • 12
    Feb
  • 29
    May
BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

Initiation
Cowen starts Instil Bio at Outperform on 'second-mover advantage' » 07:36
04/13/21
04/13
07:36
04/13/21
07:36
TIL

Instil Bio

$22.13 /

+0.05 (+0.23%)

, IOVA

Iovance Biotherapeutics

$29.41 /

-0.74 (-2.45%)

Cowen analyst Yaron…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

IOVA Iovance Biotherapeutics
$29.41 /

-0.74 (-2.45%)

TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

07:07 Today Truist
Truist starts Instil Bio with a Buy citing efficacy in solid tumors
06:18 Today Truist
Instil Bio initiated with a Buy at Truist
06:00 Today Cowen
Instil Bio initiated with an Outperform at Cowen
05:59 Today Morgan Stanley
Instil Bio initiated with an Equal Weight at Morgan Stanley
IOVA Iovance Biotherapeutics
$29.41 /

-0.74 (-2.45%)

03/08/21 H.C. Wainwright
Iovance Biotherapeutics upgraded to Buy from Neutral at H.C. Wainwright
01/29/21 Baird
Iovance Biotherapeutics assumed at Outperform at Baird
01/14/21 Oppenheimer
Iovance Biotherapeutics price target raised to $57 from $43 at Oppenheimer
12/17/20 Barclays
Iovance Biotherapeutics price target raised to $55 from $43 at Barclays
IOVA Iovance Biotherapeutics
$29.41 /

-0.74 (-2.45%)

  • 19
    Mar
  • 29
    May
TIL Instil Bio
$22.13 /

+0.05 (+0.23%)

Options
Unusual call flow in option market yesterday » 07:35
04/13/21
04/13
07:35
04/13/21
07:35
NUAN

Nuance

$52.80 /

+7.21 (+15.81%)

, VVV

Valvoline

$26.90 /

+0.405 (+1.53%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NUAN Nuance
$52.80 /

+7.21 (+15.81%)

VVV Valvoline
$26.90 /

+0.405 (+1.53%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

06:57 Today BMO Capital
BMO Capital positive on Microsoft deal for Nuance
06:22 Today Wedbush
Nuance downgraded to Neutral from Outperform at Wedbush
04/12/21 Jefferies
Microsoft deal emphasizes healthcare cloud focus, says Jefferies
04/12/21 Stifel
Microsoft a 'logical buyer' of Nuance, says Stifel
VVV Valvoline
$26.90 /

+0.405 (+1.53%)

03/22/21 Citi
Valvoline price target raised to $32 from $28 at Citi
02/08/21 Citi
Valvoline price target raised to $28 from $25 at Citi
02/04/21 Monness Crespi
Valvoline price target raised to $30 from $26 at Monness Crespi
01/11/21 Seaport Global
Valvoline downgraded to Neutral from Buy at Seaport Global
NUAN Nuance
$52.80 /

+7.21 (+15.81%)

VVV Valvoline
$26.90 /

+0.405 (+1.53%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

NUAN Nuance
$52.80 /

+7.21 (+15.81%)

VVV Valvoline
$26.90 /

+0.405 (+1.53%)

Hot Stocks
Axcella announces AXA1125's IND clearance for the treatment of NASH » 07:34
04/13/21
04/13
07:34
04/13/21
07:34
AXLA

Axcella Health

$4.24 /

-0.09 (-2.08%)

Axcella announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXLA Axcella Health
$4.24 /

-0.09 (-2.08%)

AXLA Axcella Health
$4.24 /

-0.09 (-2.08%)

03/22/21 Wedbush
Axcella Health price target lowered to $11 from $19 at Wedbush
03/18/21 Chardan
Axcella Health moving forward with two lead programs, says Chardan
11/18/20 Roth Capital
Axcella Health initiated with a Buy at Roth Capital
10/27/20
Fly Intel: Top five analyst initiations
AXLA Axcella Health
$4.24 /

-0.09 (-2.08%)

  • 14
    May
AXLA Axcella Health
$4.24 /

-0.09 (-2.08%)

Hot Stocks
Aleafia Health introduces wellness brand Noon & Night » 07:34
04/13/21
04/13
07:34
04/13/21
07:34
ALEAF

Aleafia Health

/

+

Aleafia Health announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALEAF Aleafia Health
/

+

ALEAF Aleafia Health
/

+

03/10/21 Cantor Fitzgerald
Aleafia Health initiated with a Neutral at Cantor Fitzgerald
ALEAF Aleafia Health
/

+

ALEAF Aleafia Health
/

+

Hot Stocks
Geron announces first patient dosed in IMpactMF trial » 07:34
04/13/21
04/13
07:34
04/13/21
07:34
GERN

Geron

$1.41 /

-0.075 (-5.05%)

Geron announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GERN Geron
$1.41 /

-0.075 (-5.05%)

GERN Geron
$1.41 /

-0.075 (-5.05%)

02/18/21 B. Riley Securities
Geron transferred with Buy rating at B. Riley Securities
10/14/20 B. Riley Securities
Geron shares have 100% potential upside, says B. Riley Securities
08/26/20 H.C. Wainwright
Geron price target raised to $7 from $4 at H.C. Wainwright
08/03/20
Fly Intel: Top five analyst initiations
GERN Geron
$1.41 /

-0.075 (-5.05%)

  • 22
    May
Recommendations
Mattel price target raised to $22 from $19.50 at Stifel » 07:33
04/13/21
04/13
07:33
04/13/21
07:33
MAT

Mattel

$20.28 /

+0.15 (+0.75%)

, HAS

Hasbro

$97.12 /

+1.875 (+1.97%)

Stifel analyst Drew Crum…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAT Mattel
$20.28 /

+0.15 (+0.75%)

HAS Hasbro
$97.12 /

+1.875 (+1.97%)

MAT Mattel
$20.28 /

+0.15 (+0.75%)

02/25/21
Fly Intel: Top five analyst upgrades
02/25/21 Monness Crespi
Mattel upgraded to Buy on favorable risk/reward at Monness Crespi
02/25/21 Monness Crespi
Mattel upgraded to Buy from Neutral at Monness Crespi
02/25/21 JPMorgan
Mattel price target raised to $27 from $22 at JPMorgan
HAS Hasbro
$97.12 /

+1.875 (+1.97%)

03/29/21 MKM Partners
Hasbro reached 'important milestones' in videogame business, says MKM Partners
03/15/21 Truist
Hasbro price target raised to $100 from $95 at Truist
02/09/21 DA Davidson
Hasbro price target raised to $115 from $105 at DA Davidson
02/09/21 BMO Capital
Hasbro price target lowered to $85 from $90 at BMO Capital
MAT Mattel
$20.28 /

+0.15 (+0.75%)

HAS Hasbro
$97.12 /

+1.875 (+1.97%)

MAT Mattel
$20.28 /

+0.15 (+0.75%)

MAT Mattel
$20.28 /

+0.15 (+0.75%)

HAS Hasbro
$97.12 /

+1.875 (+1.97%)

MAT Mattel
$20.28 /

+0.15 (+0.75%)

Hot Stocks
BridgeBio announces formal collaboration with Brown University » 07:33
04/13/21
04/13
07:33
04/13/21
07:33
BBIO

BridgeBio

$53.97 /

-0.51 (-0.94%)

BridgeBio Pharma and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

03/22/21 Goldman Sachs
BridgeBio price target raised to $91 from $83 at Goldman Sachs
03/22/21 Piper Sandler
BridgeBio's encaleret likely to be new standard of care, says Piper Sandler
03/04/21 Mizuho
BridgeBio price target raised to $86 from $56 at Mizuho
03/01/21 Piper Sandler
BridgeBio's first approval small but significant, says Piper Sandler
BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

  • 12
    Feb
  • 29
    May
BBIO BridgeBio
$53.97 /

-0.51 (-0.94%)

Initiation
GigCapital3 initiated with an Outperform at Northland » 07:33
04/13/21
04/13
07:33
04/13/21
07:33
GIK

GigCapital3

$10.05 /

-0.085 (-0.84%)

Northland initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIK GigCapital3
$10.05 /

-0.085 (-0.84%)

GIK GigCapital3
$10.05 /

-0.085 (-0.84%)

03/12/21 Benchmark
GigCapital3 initiated with a Buy at Benchmark
GIK GigCapital3
$10.05 /

-0.085 (-0.84%)

GIK GigCapital3
$10.05 /

-0.085 (-0.84%)

GIK GigCapital3
$10.05 /

-0.085 (-0.84%)

Hot Stocks
Lincoln Electric names Lisa Shapiro as VP, corporate controller » 07:32
04/13/21
04/13
07:32
04/13/21
07:32
LECO

Lincoln Electric

$122.23 /

+0.16 (+0.13%)

Lincoln Electric Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LECO Lincoln Electric
$122.23 /

+0.16 (+0.13%)

LECO Lincoln Electric
$122.23 /

+0.16 (+0.13%)

02/16/21 Baird
Lincoln Electric early cycle growth seen in 2021, says Baird
01/20/21 Vertical Research
Lincoln Electric initiated with a Sell at Vertical Research
12/21/20 Barclays
Lincoln Electric price target raised to $130 from $117 at Barclays
10/19/20 Barclays
Lincoln Electric upgraded to Overweight on 'best-in-class' profile at Barclays
LECO Lincoln Electric
$122.23 /

+0.16 (+0.13%)

Initiation
Connect Biopharma initiated with an Outperform at SVB Leerink » 07:32
04/13/21
04/13
07:32
04/13/21
07:32
CNTB

Connect Biopharma

$17.00 /

+0.08 (+0.47%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNTB Connect Biopharma
$17.00 /

+0.08 (+0.47%)

CNTB Connect Biopharma
$17.00 /

+0.08 (+0.47%)

04:53 Today Piper Sandler
Connect Biopharma initiated with an Overweight at Piper Sandler
  • 19
    Mar
CNTB Connect Biopharma
$17.00 /

+0.08 (+0.47%)

Hot Stocks
vTv Therapeutics receives breakthrough therapy designation for TTP399 from FDA » 07:31
04/13/21
04/13
07:31
04/13/21
07:31
VTVT

vTv Therapeutics

$2.58 /

-0.17 (-6.18%)

vTv Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VTVT vTv Therapeutics
$2.58 /

-0.17 (-6.18%)

VTVT vTv Therapeutics
$2.58 /

-0.17 (-6.18%)

VTVT vTv Therapeutics
$2.58 /

-0.17 (-6.18%)

Recommendations
Square price target raised to $310 from $300 at Needham » 07:31
04/13/21
04/13
07:31
04/13/21
07:31
SQ

Square

$265.25 /

+3.485 (+1.33%)

Needham analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

04/09/21 Credit Suisse
Square price target raised to $290 from $270 at Credit Suisse
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Oddo BHF
Square initiated with a Neutral at Oddo BHF
04/07/21 Barclays
Barclays boosts Square target to $330 on potential for international upside
SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

SQ Square
$265.25 /

+3.485 (+1.33%)

Initiation
SunOpta initiated with a Buy at Canaccord » 07:29
04/13/21
04/13
07:29
04/13/21
07:29
STKL

SunOpta

$15.02 /

+0.13 (+0.87%)

Canaccord Genuity analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STKL SunOpta
$15.02 /

+0.13 (+0.87%)

STKL SunOpta
$15.02 /

+0.13 (+0.87%)

03/04/21 Craig-Hallum
SunOpta price target raised to $25 from $15 at Craig-Hallum
02/03/21 Lake Street
SunOpta price target raised to $18 from $15 at Lake Street
12/10/20 Craig-Hallum
SunOpta initiated with a Buy at Craig-Hallum
12/09/20 Lake Street
SunOpta price target raised to $15 from $9 at Lake Street
STKL SunOpta
$15.02 /

+0.13 (+0.87%)

STKL SunOpta
$15.02 /

+0.13 (+0.87%)

Recommendations
JD.com price target lowered to $90 ahead of earnings at Morgan Stanley » 07:28
04/13/21
04/13
07:28
04/13/21
07:28
JD

JD.com

$78.68 /

-1.71 (-2.13%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

03/12/21 HSBC
JD.com price target raised to $108 from $103 at HSBC
03/12/21 UBS
JD.com price target raised to $110 from $105 at UBS
03/12/21 Citi
JD.com price target raised to $120 from $117 at Citi
01/27/21 Macquarie
JD.com price target raised to $133 from $107 at Macquarie
JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

JD JD.com
$78.68 /

-1.71 (-2.13%)

Downgrade
Aphria downgraded to Hold on industry headwinds at Canaccord » 07:28
04/13/21
04/13
07:28
04/13/21
07:28
APHA

Aphria

$13.93 /

-2.34 (-14.38%)

, TLRY

Tilray

$17.15 /

-2.62 (-13.25%)

Canaccord analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

06:31 Today Canaccord
Aphria downgraded to Hold from Speculative Buy at Canaccord
04/12/21 Alliance Global Partners
Alliance Global trims Aphria price target to C$24, says long-term view intact
04/08/21 Alliance Global Partners
Aphria price target raised to $26 from $20 at Alliance Global Partners
04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
TLRY Tilray
$17.15 /

-2.62 (-13.25%)

04/06/21 Stifel
Aphria price target raised to C$22 from C$15.50 at Stifel
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
02/18/21
Fly Intel: Top five analyst downgrades
02/18/21 Roth Capital
Tilray price target raised to $25 from $10 at Roth Capital
APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

APHA Aphria
$13.93 /

-2.34 (-14.38%)

TLRY Tilray
$17.15 /

-2.62 (-13.25%)

Downgrade
Cadence Bancorp downgraded to Hold from Buy at Truist » 07:28
04/13/21
04/13
07:28
04/13/21
07:28
CADE

Cadence Bancorp

$22.41 /

+0.92 (+4.28%)

, BXS

BancorpSouth

$30.45 /

-1.79 (-5.55%)

Truist analyst Jennifer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

BXS BancorpSouth
$30.45 /

-1.79 (-5.55%)

CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

06:37 Today Raymond James
Cadence Bancorp downgraded to Market Perform from Outperform at Raymond James
06:10 Today RBC Capital
Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital
04/12/21 RBC Capital
Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital
02/23/21 Stephens
Stephens raises Regions price target to $23, sees possible deal for Cadence
BXS BancorpSouth
$30.45 /

-1.79 (-5.55%)

06:10 Today RBC Capital
Cadence Bancorp downgraded to Sector Perform from Outperform at RBC Capital
12/03/20 Stephens
National United deal shouldn't preclude more M&A at BancorpSouth, says Stephens
11/16/20 DA Davidson
BancorpSouth downgraded to Neutral from Buy at DA Davidson
11/16/20 DA Davidson
BancorpSouth downgraded to Neutral from Buy at DA Davidson
CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

BXS BancorpSouth
$30.45 /

-1.79 (-5.55%)

CADE Cadence Bancorp
$22.41 /

+0.92 (+4.28%)

General news
European stock markets are mostly higher, » 07:25
04/13/21
04/13
07:25
04/13/21
07:25
$ECON

Economic Data

/

+

European stock markets…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Conference/Events
    Immunocore to host conference call » 07:25
    04/13/21
    04/13
    07:25
    04/13/21
    07:25
    IMCR

    Immunocore

    $32.22 /

    -3.28 (-9.24%)

    Management discusses…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    03/02/21 Jefferies
    Immunocore initiated with a Buy at Jefferies
    03/02/21 JPMorgan
    Immunocore initiated with an Overweight at JPMorgan
    03/02/21 Goldman Sachs
    Immunocore initiated with a Neutral at Goldman Sachs
    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    • 05
      Feb
    IMCR Immunocore
    $32.22 /

    -3.28 (-9.24%)

    Conference/Events
    Auris Medical to host business news update conference call » 07:25
    04/13/21
    04/13
    07:25
    04/13/21
    07:25
    EARS

    Auris Medical

    $4.26 /

    -0.015 (-0.35%)

    Management provides a…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    EARS Auris Medical
    $4.26 /

    -0.015 (-0.35%)

    Syndicate
    TripAdvisor announces pricing of Global Offering » 07:24
    04/13/21
    04/13
    07:24
    04/13/21
    07:24
    TRIP

    TripAdvisor

    $51.17 /

    -1.27 (-2.42%)

    announced the pricing of…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    07:10 Today Jefferies
    TripAdvisor price target raised to $29 from $24 at Jefferies
    04/05/21 Evercore ISI
    TripAdvisor assumed with an In Line at Evercore ISI
    03/31/21 Wolfe Research
    TripAdvisor initiated with a Peer Perform at Wolfe Research
    03/12/21 Truist
    TripAdvisor price target raised to $62 from $48 at Truist
    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    TRIP TripAdvisor
    $51.17 /

    -1.27 (-2.42%)

    Upgrade
    Ameren upgraded to Buy from Neutral at BofA » 07:24
    04/13/21
    04/13
    07:24
    04/13/21
    07:24
    AEE

    Ameren

    $80.70 /

    +0.15 (+0.19%)

    BofA analyst Julien…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    AEE Ameren
    $80.70 /

    +0.15 (+0.19%)

    AEE Ameren
    $80.70 /

    +0.15 (+0.19%)

    07:01 Today BofA
    Ameren upgraded to Buy from Neutral at BofA
    04/08/21 Mizuho
    Ameren initiated with a Neutral at Mizuho
    11/18/20 Barclays
    Ameren upgraded to Equal Weight from Underweight at Barclays
    09/21/20 Barclays
    Ameren downgraded to Underweight from Equal Weight at Barclays
    AEE Ameren
    $80.70 /

    +0.15 (+0.19%)

    Initiation
    B. Riley starts GT Biopharma with Buy, sees 101% upside in shares » 07:22
    04/13/21
    04/13
    07:22
    04/13/21
    07:22
    GTBP

    GT Biopharma

    $10.29 /

    -0.1 (-0.96%)

    B. Riley analyst Justin…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GTBP GT Biopharma
    $10.29 /

    -0.1 (-0.96%)

    GTBP GT Biopharma
    $10.29 /

    -0.1 (-0.96%)

    04:47 Today B. Riley
    GT Biopharma initiated with a Buy at B. Riley
    03/17/21 Roth Capital
    GT Biopharma initiated with a Buy at Roth Capital
    • 11
      Feb
    Recommendations
    Cleveland-Cliffs price target raised to $22 from $21 at B. Riley » 07:20
    04/13/21
    04/13
    07:20
    04/13/21
    07:20
    CLF

    Cleveland-Cliffs

    $17.54 /

    -0.285 (-1.60%)

    B. Riley analyst Lucas…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    04/09/21 Goldman Sachs
    Cleveland-Cliffs initiated with a Neutral at Goldman Sachs
    03/31/21 B. Riley Securities
    Cleveland-Cliffs price target raised to $21 from $20 at B. Riley Securities
    02/03/21 Credit Suisse
    U.S. Steel Industry upgraded to Overweight at Credit Suisse
    01/26/21 GLJ Research
    Cleveland-Cliffs downgraded to Hold on 'emerging headwinds' at GLJ Research
    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    • 09
      Feb
    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    CLF Cleveland-Cliffs
    $17.54 /

    -0.285 (-1.60%)

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.